title: [Systemic lupus and biotherapy: 2010 update].
authors.affiliation: Service de médecine interne-2, centre national de référence lupus systémique et syndrome des anticorps anti-phospholipides, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Arnaud
authors.forename: Z
authors.initials: Z
authors.lastname: Amoura
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects; D001691:Biological Therapy / Q000379:methods / Q000639:trends; D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D019317:Evidence-Based Medicine; D006801:Humans; D007155:Immunologic Factors / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000037:antagonists & inhibitors; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D044087:Receptor, Anaphylatoxin C5a / Q000037:antagonists & inhibitors; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D044087:Receptor, Anaphylatoxin C5a; D051918:Sialic Acid Binding Ig-like Lectin 2; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma
vernacular_title: Lupus systémique et biothérapies: mise au point en 2010.